Aims: To perform a comparative analysis of individual clinical and laboratory indicators in the differential diagnosis of conditionally limited and generalized forms of postpartum septic complications. Methods: The study included 34 patients at Gynecology Department of the Zaporizhzhia Regional Clinical Hospital from 2013 to 2016 with postpartum purulent-septic diseases. Patients were divided into 2 groups. Group I consisted of 15 women who were diagnosed with a conditionally limited postpartum purulent-inflammatory disease (endometritis). Group II included 19 women with generalized forms of postpartum purulent-inflammatory diseases (peritonitis, sepsis). For the diagnosis of Multiple Organ Failure due to sepsis, we used the Sequential (Sepsis-Related) Organ Failure Assessment and quick Sequential (Sepsis-Related) Organ Failure Assessment. The differences between the first and second group were assessed by using the Mann-Whitney U test and STATISTICA Version 10. Results: Body temperature was increased in all 34 patients. The average heart rate in group I was 91.6 ± 8.35 beats/ min and 102.26 ± 16.42 beats/min in group II. The average respiratory rate was 19.07 ± 2.49 breaths/min in group I and 24.16 ± 5.09 breaths/min in group II. In group I, none of the patients scored a total of two or more points on the Sequential (Sepsis-Related) Organ Failure Assessment and quick Sequential (Sepsis-Related) Organ Failure Assessment scales; in group II, there were 5 (26.32%) patients who had scored two points or more on the Sequential (Sepsis-Related) Organ Failure Assessment scale; and 2 (10.53%) patients had scored 2 points or more in the quick Sequential (Sepsis-Related) Organ Failure Assessment scale. Conclusion: Clinical cases of postpartum period with inflammation of uterus and signs of multiple organ failure should be; regarded as a septic state, assessed by the Sequential (Sepsis-Related) Organ Failure Assessment scale as they require urgent medical help.
Aims: To investigate modern methods to prevent premature rupture of membranes by the use of chlorhexidine in pregnant women with varicose disease. Methods: The data of 39 pregnant women with varicose disease, who delivered between 2014 and 2016 at Maternity Hospital No. 3, Zaporozhye were analyzed using SPSS software. Patients were divided in 3 groups according to their medical history, complications during pregnancy, childbirth and postpartum period. The 1st group consisted of 13 pregnant women who did not receive prenatal vaginal douching with chlorhexidine; the 2nd group consisted of 13 patients with varicose disease, who received douching of birth canal with vaginal suppositories with chlorhexidine 1 time per day for 10 days before their delivery, but did not undergo a rehabilitation at the sanatorium; and the 3rd group had 13 pregnant women who received sanatorium rehabilitation at ''Veliki lug'' during the II. trimester of their pregnancy with the course of 1 chlorhexidine suppository per day for 10 days before delivery. Results: In the 1st group, the percentage of premature death was 61.5%; anemia and significant ultrasound markers were present in 46.2%; the percentage for the presence of hematometra was 38.5%; premature rupture of membranes, anomalies of labor and polyhydroamniosis were 30.8%; chorioamnionitis 15.4%; and intrauterine infection of fetus was 7.7%. In the 2nd group, anemia was present in 35%, 23.1% showed anomalies of labor; premature rupture of membranes, ultrasound markers, premature death, and hematometra were present in 15.4%. Whereas in the 3rd group, anemia and anomalies of labor were present in 15.4%, premature rupture of the membranes and premature death were present in 7.7% of the patients. Conclusion: With its broad antibacterial and antiviral effect, chlorhexidine in antiseptic form was found to be beneficial and it is found to promote the restoration of the vaginal microflora.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.